Efficacy and safety of orlistat in male patients with overweight/obesity and hyperuricemia: results of a randomized, double-blind, placebo-controlled trial

Abstract Background Obesity is associated with elevated serum uric acid (SUA) levels and frequent gout flares. Losing weight can reduce the SUA level and gout flares. The effect of orlistat on SUA levels and gout flares in patients with overweight/obesity and hyperuricemia (HUA) has not been extensi...

Повний опис

Бібліографічні деталі

Автори:	Shuang Liu, Xiaojing Lin, Minghao Tao, Qi Chen, Hang Sun, Yali Han, Shaoling Yang, Yining Gao, Shen Qu, Haibing Chen
Формат:	Artigo
Мова:	Inglês
Опубліковано:	BMC 2024-03-01
Серія:	Lipids in Health and Disease
Предмети:	Hyperuricemia Orlistat Uric acid Gout flare
Онлайн доступ:	https://doi.org/10.1186/s12944-024-02047-7
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!